• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - HUNTINGTON MONARCH III IOL DELIVERY SYSTEM, CARTRIDGE D; FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - HUNTINGTON MONARCH III IOL DELIVERY SYSTEM, CARTRIDGE D; FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL) Back to Search Results
Catalog Number 8065977763
Device Problem Device Contamination with Chemical or Other Material (2944)
Patient Problems Bacterial Infection (1735); Endophthalmitis (1835); Inflammation (1932)
Event Date 03/27/2023
Event Type  Injury  
Event Description
A physician reported that during the intraocular lens (iol) implant procedure, the physician complained that whitish fluffy material came out from cartridge.The physician washed it and administered anti bacterial drug thinking that there wont be any problem.However customer complained that the patient diagnosed with endophthalmitis and was suspecting the cartridge.The event was ongoing at the time of the report.The patient was hospitalized due to the event and the patient eye fluid was positive for pseudomonas aeruginosa.Additional information has been requested.Additional information received and stated that, uneventful left eye cataract surgery, noticed while fluffy material on iol implantation.Immediately removed the material with few bits entered in to the bay injected intracranial anti-bacterial, but still developed endophthalmitis with pseudomonal positive culture.Pain developed on 4th day after diminished vision, indicating vitritis first followed by unspecified reaction.The surgeon suspecting fluffy particle in cartridge.The lab data is positive for pseudomonas.The surgeon diagnosed endophthalmitis and toxic anterior segment syndrome.Intervention for the event was vitrectomy, anterior chamber wash, topical medication adjustment and iol explanation.Other treatment include: intravenous antibiotics, ceftriaxone, vancomycin, imipenem, olishia (unspecified).Intervention outcome for the event was unknown.It was stated that to some extent still patient is having continued fatigue.Event outcome continuing at the time of the report.There were no surgical complications.The event resulted clinically significant change.
 
Manufacturer Narrative
The product was not returned for analysis.Complaint and product history records were reviewed and documentation indicated the product met release criteria.Root cause has not been identified.The manufacturer internal reference number is:(b)(4).
 
Manufacturer Narrative
The handpiece and viscoelastic used were not provided.It is unknown if qualified products were used.The product investigation could not identify a root cause for the reported foreign material.The company cartridge complaint product was not returned for evaluation.It cannot be determined if the cartridge was damaged.No determination can be made without physical evaluation of the complaint sample.The nature and origin of the material is unknown.The root cause for the reported endophthalmitis cannot be determined.Information was provided that the lens was removed and sent for testing.The results indicated the presence of pseudomonas aeruginosa.This would be unrelated to the company cartridge or the iol.Company cartridges and iols are terminally sterilized with 100% ethylene oxide sterilization.Company uses an overkill sterilization approach, which greatly exceeds the minimum requirements for sterility.Critical parameters for sterilization cycles are recorded and retained for every sterilization load to demonstrate that the acceptance criteria for the sterilization process are met.Pseudomonas aeruginosa is found in soil, water, skin flora, and most man-made environments throughout the world.Postoperative endophthalmitis caused by p.Aeruginosa has been reported in literature secondary to contamination of surgical solutions, instruments, or equipment.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MONARCH III IOL DELIVERY SYSTEM, CARTRIDGE D
Type of Device
FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL)
Manufacturer (Section D)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer (Section G)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key16823797
MDR Text Key314097389
Report Number1119421-2023-00790
Device Sequence Number1
Product Code MSS
UDI-Device Identifier00380659777639
UDI-Public00380659777639
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
K063155
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/26/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number8065977763
Device Lot Number15496171
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/31/2023
Initial Date FDA Received04/27/2023
Supplement Dates Manufacturer Received05/31/2023
Supplement Dates FDA Received06/26/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/14/2022
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ACRYSOF SINGLEPIECE IOL.
Patient Outcome(s) Other; Hospitalization;
Patient Age60 YR
Patient SexMale
Patient Weight80 KG
-
-